SOLX, Inc. is an emerging leader in the management and surgical treatment of glaucoma, a leading cause of blindness in the world. Founded in 2000 by a serial ophthalmology entrepreneur, SOLX is financially-backed by MVM Life Science Partners, a leading global life science venture capital firm.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/19/12 | $3,300,000 |
MVM Partners | undisclosed | |
| 11/30/16 | undisclosed | Strategic |
Spotlight Innovation | undisclosed |
